NDC 57841-1201

Aemcolo

Rifamycin

Aemcolo is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Redhill Biopharma Ltd. The primary component is Rifamycin.

• Product ID: 57841-1201_2896e337-7410-4532-bea3-f0a65ef7135a
• NDC: 57841-1201
• Product Type: Human Prescription Drug
• Proprietary Name: Aemcolo
• Generic Name: Rifamycin
• Dosage Form: Tablet, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-01
• Marketing Category: NDA /
• Application Number: NDA210910
• Labeler Name: RedHill Biopharma Ltd
• Substance Name: RIFAMYCIN
• Active Ingredient Strength: 194 mg/1
• Pharm Classes: Rifamycin Antibacterial [EPC], Rifamycins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 57841-1201-1

1 BLISTER PACK in 1 CARTON (57841-1201-1) > 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK (57841-1201-0)

• Marketing Start Date: 2021-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Aemcolo" or generic name "Rifamycin"

NDC	Brand Name	Generic Name
57841-1200	Aemcolo	Rifamycin
57841-1201	Aemcolo	Rifamycin
71068-001	Aemcolo	Rifamycin